1Kirchhoff C. Molecular characterization of epididymalproteins[J3. Rev Reprod,1998,3(2) : 86-95.
2Galgano MT, Hampton GM,Frierson HF Jr. Compre-hensive analysis of HE4 expression in normal and malig-nant human tissues[ J]. Mod Pathol,2006,19(6) : 847-853.
6Anastasi E, Marchei GG,Viggiani V,et al. HE4 : a newpotential early biomarker for the recurrence of ovariancancer[J], Tumour Biol,2010,31 (2) : 113-119.
8Moore RG,Miller CM,Brown AK,et al. Utility oftumor marker HE4 to predict depth of myometrial inva-sion in endometrioid adenocarcinoma of the uterus[J],Gynecol Cancer,2011 .21(7) : 1185-1190.
9Bignotti E, Ragnoli M, Zanotti L, ^ al. Diagnostic and.prognostic impact of serum HE4 detection in endometri-al carcinoma patients [J]. Br J Cancer, 2011, 104 ( 9 ):1418-1425.
10Kamei M, Yamashita S, Tokuishi K^et al. HE4 expres-sion can be associated with lymph node metastases anddisease-free survival in breast cancer [J]. AnticancerRes,2010,30(11): 4779-4783.
5Moore RG, Mc Meekin DS, Brown AK, et al. A novel multiple marker bioassay utillzing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass[ J]. Gynecol Oncol, 2009, 112 (1) :40 -46.
6Moore RG, Brown AK, Miller MC, et al. Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus [ J ]. Gynecol Oncol, 2008, 110 ( 2 ) : 196 - 201.
7Hellstrom I, Raycraft J, Hayden - Ledbetter M, et al. The HFA (WFDC2) protein is a biomarker for ovarian carcinoma [ J ]. Cancer Res, 2003, 63 ( 13 ) : 3695 - 3700.
8Moore RG, Brown AK, Miller MC, et al. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass[J]. Gynecol Oncol, 2008, 108(2) :405.
9Kirchhoff C, Habben I, Ivell R, et al. A major human epididymis - specific CDNA encodes a protein with sequence homology to extracellu-lar proteinase inhibitors[ J]. Biol Reprod, 1991,45:350-357.
10Moore RG,Mcmeekin DS,Brown AK,et al.A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.Gynecol Oncol,2009,112:40-46.
